Neglected Tropical Diseases Drugs and Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neglected Tropical Diseases Drugs and Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neglected Tropical Diseases Drugs and Vaccine Overall Market Size
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2023 VS 2030
2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.2 Top Global Neglected Tropical Diseases Drugs and Vaccine Companies Ranked by Revenue
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Neglected Tropical Diseases Drugs and Vaccine Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Market Size Markets, 2023 & 2030
4.1.2 Malaria
4.1.3 Ebola
4.1.4 Dengue
4.1.5 Chagas
4.1.6 Leishmaniasis
4.1.7 Other
4.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
4.2.1 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2023 & 2030
5.1.2 Drugs
5.1.3 Vaccines
5.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
5.2.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
6.2.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.3.2 US Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.3.3 Canada Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.3.4 Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.4.2 Germany Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.3 France Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.4 U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.5 Italy Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.6 Russia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.7 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.8 Benelux Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.5.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.4 South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.5 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.6 India Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.6.2 Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.6.3 Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.7.2 Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7.3 Israel Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7.4 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7.5 UAE Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
7 Neglected Tropical Diseases Drugs and Vaccine Companies Profiles
7.1 Artecef BV
7.1.1 Artecef BV Company Summary
7.1.2 Artecef BV Business Overview
7.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.1.5 Artecef BV Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.4.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Sanofi-Aventis
7.5.1 Sanofi-Aventis Company Summary
7.5.2 Sanofi-Aventis Business Overview
7.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.5.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.5.5 Sanofi-Aventis Key News & Latest Developments
7.6 Ranbaxy Labs
7.6.1 Ranbaxy Labs Company Summary
7.6.2 Ranbaxy Labs Business Overview
7.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.6.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.6.5 Ranbaxy Labs Key News & Latest Developments
7.7 Lupin
7.7.1 Lupin Company Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.7.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.7.5 Lupin Key News & Latest Developments
7.8 Macleods Pharmaceuticals
7.8.1 Macleods Pharmaceuticals Company Summary
7.8.2 Macleods Pharmaceuticals Business Overview
7.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.8.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.8.5 Macleods Pharmaceuticals Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.9.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.9.5 Cipla Key News & Latest Developments
7.10 Romark Laboratories
7.10.1 Romark Laboratories Company Summary
7.10.2 Romark Laboratories Business Overview
7.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.10.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.10.5 Romark Laboratories Key News & Latest Developments
7.11 Toyama Chemica
7.11.1 Toyama Chemica Company Summary
7.11.2 Toyama Chemica Business Overview
7.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.11.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.11.5 Toyama Chemica Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neglected Tropical Diseases Drugs and Vaccine Market Opportunities & Trends in Global Market
Table 2. Neglected Tropical Diseases Drugs and Vaccine Market Drivers in Global Market
Table 3. Neglected Tropical Diseases Drugs and Vaccine Market Restraints in Global Market
Table 4. Key Players of Neglected Tropical Diseases Drugs and Vaccine in Global Market
Table 5. Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 9. List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 30. Artecef BV Company Summary
Table 31. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 32. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 33. Artecef BV Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 36. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 40. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 44. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 45. Novartis Key News & Latest Developments
Table 46. Sanofi-Aventis Company Summary
Table 47. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 48. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 49. Sanofi-Aventis Key News & Latest Developments
Table 50. Ranbaxy Labs Company Summary
Table 51. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 52. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 53. Ranbaxy Labs Key News & Latest Developments
Table 54. Lupin Company Summary
Table 55. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 56. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 57. Lupin Key News & Latest Developments
Table 58. Macleods Pharmaceuticals Company Summary
Table 59. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 60. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 61. Macleods Pharmaceuticals Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 64. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 65. Cipla Key News & Latest Developments
Table 66. Romark Laboratories Company Summary
Table 67. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 68. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 69. Romark Laboratories Key News & Latest Developments
Table 70. Toyama Chemica Company Summary
Table 71. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 72. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 73. Toyama Chemica Key News & Latest Developments
List of Figures
Figure 1. Neglected Tropical Diseases Drugs and Vaccine Segment by Type in 2023
Figure 2. Neglected Tropical Diseases Drugs and Vaccine Segment by Application in 2023
Figure 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
Figure 8. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 16. US Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 20. Germany Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 21. France Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 28. China Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. India Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 34. Brazil Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 37. Turkey Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)